Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Lenalidomide-induced diarrhea in patients with myeloma is caused by bile acid malabsorption that responds to treatment.

Literature DB >> 25301337

Lenalidomide-induced diarrhea in patients with myeloma is caused by bile acid malabsorption that responds to treatment.

Charlotte Pawlyn¹, Mohid S Khan², Ann Muls³, Priya Sriskandarajah⁴, Martin F Kaiser¹, Faith E Davies¹, Gareth J Morgan¹, H Jervoise N Andreyev³.

Abstract

Entities: Chemical Disease Species

Mesh：

Substances：

Year: 2014 PMID： 25301337 DOI： 10.1182/blood-2014-06-583302

Source DB: PubMed Journal: Blood ISSN： 0006-4971 Impact factor: 22.113

Keyword Cloud
Cited

× No keyword cloud information.

17 in total

1. Targeting precision medicine toxicity: recent developments.

Authors: Gordon Mallarkey; Arduino A Mangoni
Journal: Ther Adv Drug Saf Date: 2015-02

Review 2. Case-based roundtable on treatment approach for young, fit, newly diagnosed multiple myeloma patients.

Authors: Sergio Giralt; Eric Seifter
Journal: Hematology Am Soc Hematol Educ Program Date: 2018-11-30

Review 3. Management of Mantle Cell Lymphoma in the Era of Novel Oral Agents.

Authors: Michael J Buege; Anita Kumar; Brianne N Dixon; Laura A Tang; Terry Pak; Jennifer Orozco; Tim J Peterson; Kathryn T Maples
Journal: Ann Pharmacother Date: 2020-02-20 Impact factor: 3.154

Review 4. Therapy for Relapsed Multiple Myeloma: Guidelines From the Mayo Stratification for Myeloma and Risk-Adapted Therapy.

Authors: David Dingli; Sikander Ailawadhi; P Leif Bergsagel; Francis K Buadi; Angela Dispenzieri; Rafael Fonseca; Morie A Gertz; Wilson I Gonsalves; Susan R Hayman; Prashant Kapoor; Taxiarchis Kourelis; Shaji K Kumar; Robert A Kyle; Martha Q Lacy; Nelson Leung; Yi Lin; John A Lust; Joseph R Mikhael; Craig B Reeder; Vivek Roy; Stephen J Russell; Taimur Sher; A Keith Stewart; Rahma Warsame; Stephen R Zeldenrust; S Vincent Rajkumar; Asher A Chanan Khan
Journal: Mayo Clin Proc Date: 2017-03-11 Impact factor: 7.616

Lenalidomide-induced diarrhea in patients with myeloma is caused by bile acid malabsorption that responds to treatment.

1. Targeting precision medicine toxicity: recent developments.

Review 2. Case-based roundtable on treatment approach for young, fit, newly diagnosed multiple myeloma patients.

Review 3. Management of Mantle Cell Lymphoma in the Era of Novel Oral Agents.

Review 4. Therapy for Relapsed Multiple Myeloma: Guidelines From the Mayo Stratification for Myeloma and Risk-Adapted Therapy.

5. Supportive care in multiple myeloma: Current practices and advances.

Review 6. Common Adverse Effects of Novel Therapies for Multiple Myeloma (MM) and Their Management Strategies.

Review 7. Nuances in the Management of Older People With Multiple Myeloma.

Review 8. Update on Bile Acid Malabsorption: Finally Ready for Prime Time?

9. What is the cost of delayed diagnosis of bile acid malabsorption and bile acid diarrhoea?

Review 10. Cancer therapies based on targeted protein degradation - lessons learned with lenalidomide.